Dashboard

World Health Organization. Antimicrobial Resistance Map.

Articles

Malania L, Wagenaar I, Karatuna O, Tambic Andraesevic A, Tsereteli D, Baidauri M, Imnadze P, Nahrgang S, Ruesen C. Setting up laboratory-based antimicrobial resistance surveillance in low- and middle-income countries: lessons learned from Georgia. ScienceDirect 2021; 27(10):1409-1413.

Van Prehn J, van Triest MI, Altorf-van der Kuil W, van Dijk K; Dutch National AMR Surveillance Study Group. Third-generation cephalosporin and carbapenem resistance in Streptococcus mitis/oralis. Results from a nationwide registry in the Netherlands.   Clin Microbiol Infect 2019; 25(4):518-520

Woudt SHS, de Greeff S1, Schoffelen A1, Vlek ALM, Bonten MJM; Infectious Diseases Surveillance Information System–Antimicrobial Resistance (ISIS-AR) Study Group
Antibiotic resistance and the risk of recurrent bacteremia
Clin Infect Dis 2018; 66(11):1651-7

Altorf-van der Kuil W, Schoffelen AF, de Greeff SC, Thijsen SF, Alblas HJ, Notermans DW, Vlek AL, van der Sande MA, Leenstra T; The National Amr Surveillance Study Group.
National laboratory-based surveillance system for antimicrobial resistance: a successful tool to support the control of antimicrobial resistance in the Netherlands.
Euro Surveill 2017; 22(46):pii.17-00062

Vlek AL, Frentz D, Haenen A, Bootsma HJ, Notermans DW, Frakking FN, de Greeff SC, Leenstra T; ISIS-AR study group.
Detection and epidemiology of carbapenemase producing Enterobacteriaceae in the Netherlands in 2013-2014
Eur J Clin Microbiol Infect Dis 2016; 35(7):1089-96

Koningstein M, van der Bij AK, de Kraker ME, Monen JC, Muilwijk J, de Greeff SC, Geerlings SE, van Hall MA; ISIS-AR Study Group
Recommendations for the empirical treatment of complicated urinary tract infections using surveillance data on antimicrobial resistance in the Netherlands
PLoS One. 2014 Jan 28;9(1):e86634. doi: 10.1371/journal.pone.0086634. PubMed PMID: 24489755; PubMed Central PMCID: PMC3904917

Houben AJ, Oostdijk EA, van der Voort PH, Monen JC, Bonten MJ, van der Bij AK; ISIS-AR Study Group
Selective decontamination of the oropharynx and the digestive tract, and antimicrobial resistance: a 4 year ecological study in 38 intensive care units in the Netherlands
J Antimicrob Chemother. 2014 Mar;69(3):797-804. doi: 10.1093/jac/dkt416. PubMed PMID: 24144922

Leverstein-van Hall MA, Waar K, Muilwijk J, Cohen Stuart J; ISIS-AR Study Group
Consequences of switching from a fixed 2 : 1 ratio of amoxicillin/clavulanate (CLSI) to a fixed concentration of clavulanate (EUCAST) for susceptibility testing of Escherichia coli.
J Antimicrob Chemother. 2013 Nov;68(11):2636-40. doi: 10.1093/jac/dkt218. PubMed PMID: 23766488

van der Bij AK, van Dijk K, Muilwijk J, Thijsen SF, Notermans DW, de Greeff S, van de Sande-Bruinsma N; ISIS-AR study group
Clinical breakpoint changes and their impact on surveillance of antimicrobial resistance in Escherichia coli causing bacteraemia
Clin Microbiol Infect. 2012 Nov;18(11):E466-72. doi: 10.1111/j.1469-0691.2012.03996.x. PubMed PMID: 22925456

                                                                                                                                                                                                                                                                     

Reports

Antimicrobial resistance surveillance in Europe. 2021 data. European Centre for Disease Prevention and Control and World Health Organization Regional Office for Europe, 2023

Surveillance of antimicrobial resistance in Europe, 2021 data: executive summary. European Centre for Disease Prevention and Control and World Health Organization Regional Office for Europe, 2023

Central Asian and European Surveillance of Antimicrobial Resistance: CAESAR manual: version 3.0, 2019. World Health Organization, 2021

NETHMAP / MARAN 2023

NETHMAP / MARAN 2022

NETHMAP / MARAN 2021

NETHMAP / MARAN 2020

NETHMAP / MARAN 2019

NETHMAP / MARAN 2018

NETHMAP / MARAN 2017

NETHMAP / MARAN 2016

NETHMAP / MARAN 2015

NETHMAP / MARAN 2014

NETHMAP / MARAN 2013

NETHMAP / MARAN 2012

CAESAR Annual report 2020
CAESAR Annual report 2019

Evaluation report: proof-of-principe routine diagnostic project for antimicrobial resistance surveillance (2017)